Skip to main content
915 TLDR
Health
1 read

Trump Administration's Move to Reclassify Marijuana Could Boost Medical Research

KTSM••Dylan McKim
Medical stethoscope representing healthcare news

Want the full story?

Read the complete article at KTSM

Read Original

AI Summary

President Donald Trump has announced plans to reclassify marijuana from a Schedule I to a Schedule III controlled substance. This significant change is expected to facilitate larger clinical studies focused on the medicinal applications of marijuana, according to medical professionals. The reclassification could open doors for more comprehensive research, potentially leading to new treatments and therapies. This decision is particularly impactful for patients seeking alternative medical options and for researchers looking to explore the benefits of cannabis in healthcare.

politics health marijuana medicine research

People & Organizations

Donald Trump

Related Articles

KTSM•Jan 1

Major Savings for Medicare Part D Seniors on 10 Essential Medications in 2026

Starting January 1, 2026, seniors enrolled in Medicare Part D will benefit from reduced costs on 10 high-priced medications that are crucial for managing chronic conditions. This change is significant as it aims to alleviate the financial burden on elderly patients who depend on these essential drugs. The adjustments in pricing are part of broader efforts to make healthcare more affordable for seniors. Medicare beneficiaries should prepare to take advantage of these savings as they plan their healthcare budgets for the upcoming year.

Health
1 min read
KTSM•Jan 1

Upcoming Drug Price Increases Affecting Over 350 Medications in 2026

A recent analysis indicates that the prices of more than 350 medications in the United States are set to increase in 2026, despite commitments from various drug manufacturers to provide more affordable options under new policies from the Trump administration. This potential rise in costs could significantly impact patients relying on these medications, raising concerns about access to necessary treatments. As the healthcare landscape continues to evolve, residents should stay informed about these changes and consider discussing their medication options with healthcare providers.

Health
1 min read
KVIA•Jan 1

Trump Reveals High Aspirin Dosage Amid Health Concerns in Recent Interview

In a recent interview with The Wall Street Journal, President Donald Trump disclosed that he takes a higher dosage of aspirin than recommended by his doctors, attributing visible bruises on his hands to this practice. At 79 years old, Trump faces increasing scrutiny regarding his health and fitness for office, especially after the appearance of bruises and swelling during public events. His physician, Dr. Sean Barbabella, stated that Trump takes 325 milligrams of aspirin daily, which exceeds the typical recommendation of 75 to 100 milligrams. Medical experts express concern over the potential risks associated with such a high dosage, emphasizing the need for transparency regarding Trump's health. The White House maintains that Trump is in excellent health, with evaluations showing cardiovascular health significantly better than his age.

Health
1 min read
KTSM•Jan 1

Measles Cases Surge to Highest Level in Three Decades, CDC Warns

The Centers for Disease Control and Prevention (CDC) has reported a significant increase in measles cases, reaching the highest levels seen in 30 years. This resurgence raises concerns about the potential revocation of the disease's elimination status, which was declared in the U.S. in 2000. The rise in cases could have serious implications for public health, particularly affecting communities with lower vaccination rates. Residents are urged to ensure their vaccinations are up to date to help prevent further outbreaks.

Health
1 min read